Surreal illustration of antimicrobial resistance in shrimp.

Shrimp SOS: Unmasking Antimicrobial Resistance to Save Your Seafood Supper

"A deep dive into the threats facing Pacific white shrimp and what it means for your plate"


Imagine biting into a succulent shrimp, only to realize that what you’re eating is a product of a system battling a silent enemy: antimicrobial resistance. Acute hepatopancreatic necrosis disease (AHPND), initially known as early mortality syndrome (EMS), has been wreaking havoc on shrimp farms since 2011, causing massive economic losses.

Vibrio parahaemolyticus, the bacteria behind AHPND, carries Photorhabdus insect-related (Pir) toxins and is becoming increasingly resistant to antimicrobials. This isn't just a problem for shrimp farmers; it's a growing concern for public health. Antimicrobial resistance (AMR) not only complicates animal treatment but also raises serious questions about the safety of our food supply and environment.

A recent study investigated antimicrobial resistance profiles in Vibrio parahaemolyticus isolates from Pacific white shrimp and pond water in Thailand. The goal was to understand better the spread and impact of AMR in shrimp farming, focusing on quinolone resistance and the presence of the pirAB-like gene. This research highlights the urgent need to monitor and manage antimicrobial use in aquaculture to protect both the industry and public health.

AI Search Multiple angles on this topic

Documented Resistance and Data Gaps

Research on shrimp aquaculture has identified key antimicrobial resistance gene (ARG) types in bacteria associated with production systems, including their resistance mechanisms and clinical relevance. A 2023 study examined tetracycline resistance determinants and integron-associated antibiotic resistance genes among motile aeromonads from a fish-farming environment. Researchers caution that the true scale of AMR dissemination in the shrimp industry remains difficult to assess because reliable antibiotic-use data are hard to obtain.

A Challenging Surveillance Problem

Assessing antimicrobial resistance in shrimp aquaculture generally depends on surveillance of resistant bacteria, resistance genes, and antibiotic-use patterns. Such monitoring can indicate where resistance occurs, but its findings may be incomplete when sampling is limited or antibiotic-use records are inconsistent. Results should therefore be interpreted cautiously, particularly when they are used to estimate the overall scale of AMR across the shrimp sector.

From Disease Control to Resistance

Antibiotics became established in shrimp farming as an alternative means of combating diseases that substantially affected production. Reviews and industry reporting describe numerous studies documenting antibiotic resistance in bacteria from shrimp farms. They also connect irrational, excessive, or incomplete antibiotic use in veterinary and human settings with the release of antibiotics and resistance into the environment.

What Does Antimicrobial Resistance Mean for Your Shrimp Dinner?

Surreal illustration of antimicrobial resistance in shrimp.

The study, conducted across seven provinces in Thailand, examined 66 isolates of V. parahaemolyticus from Pacific white shrimp and their pond water. Researchers used disc diffusion assays to assess the bacteria's resistance to common antimicrobials. Worryingly, a high percentage of isolates showed resistance to ampicillin (98.48%), while lower percentages were resistant to doxycycline (3.03%), oxytetracycline (4.55%), erythromycin (6.06%), florfenicol (1.52%), and trimethoprim/sulfamethoxazole (1.52%).

Quinolones, a class of antimicrobials widely used in both humans and animals, are of particular concern. While the isolates in the study were not fully resistant to quinolone agents like ciprofloxacin, enrofloxacin, norfloxacin, and ofloxacin, some showed intermediate susceptibility. This prompted further investigation into plasmid-mediated quinolone resistance (PMQR) genes.

  • PMQR Genes: Nine PMQR genes were screened to understand better the mechanisms of quinolone resistance. Only the qnrVC quinolone-resistant gene was found in one multidrug-resistant (MDR) isolate collected from pond water.
  • The PirAB-like Gene: A significant 39.39% of all isolates carried the pirAB-like gene, responsible for causing acute hepatopancreatic necrosis disease in shrimp. This gene was found exclusively in shrimp samples, not in the water.
  • GyrA Subtyping: By analyzing the gyrA sequence, researchers classified the isolates into five types. The pirAB-like virulent gene was present in three different types, while the MDR isolates belonged to a single type.
AI Search Multiple angles on this topic

An Evolving Evidence Base

Recent reviews examine antimicrobial resistance in shrimp aquaculture through several connected lenses, including antibiotic use, resistance pathways, environmental exposure, and potential public-health consequences. The available evidence is still developing, and researchers continue to refine how resistance genes and resistant bacteria are identified across farming systems. This makes ongoing surveillance and synthesis important for understanding the problem without overstating what current studies can establish.

Limits of Current Evidence

The case for widespread concern does not eliminate uncertainty about the size or distribution of the risk. Differences in sampling, testing, reporting, and antibiotic-use information can make studies difficult to compare directly. Consequently, the absence of evidence in a particular survey should not automatically be treated as evidence that resistance is absent, while isolated findings should not automatically represent the entire shrimp industry.

Comparing Evidence Carefully

Comparisons among shrimp-farming studies are most useful when they account for differences in location, production practices, sampled organisms, and laboratory methods. A resistance pattern found in one farm environment may not describe all shrimp-producing regions. Careful comparison should therefore emphasize recurring patterns while treating numerical differences and local findings as context-dependent.

These findings emphasize that even low antimicrobial resistance rates can pose a risk. The presence of MDR isolates and their ability to acquire plasmid resistance genes suggests a potential for AMR dissemination in the environment. Constant vigilance and responsible antimicrobial use are critical to mitigating this risk.

Protecting Our Plates: The Future of Shrimp Farming

The study's findings serve as a wake-up call for the aquaculture industry and consumers alike. While V. parahaemolyticus in this study presented low antimicrobial resistance rates, the few isolates that presented MDR profiles and their capabilities to acquire a plasmid resistant gene indicate the risk of AMR dissemination in the environment. By implementing responsible antimicrobial practices and maintaining rigorous monitoring programs, we can safeguard the health of our shrimp and ensure a safer, more sustainable food supply for the future.

AI Search Multiple angles on this topic

A Connected Risk

Taken together, the evidence suggests that antimicrobial resistance in shrimp aquaculture is linked to antibiotic use, resistant bacteria, resistance genes, and environmental pathways. The issue cannot be evaluated solely at the farm level because resistance may move through connected production and environmental systems. A responsible synthesis should recognize both the documented concern and the continuing limitations in surveillance data.

Beyond Conventional Antibiotics

A 2025 review identifies rampant antibiotic use in shrimp farming as a factor pushing culture systems toward antibiotic-resistant bacteria. A 2026 study presents recombinant antimicrobial peptides (AMPs) as potential safe and sustainable alternatives, emphasizing their consistent and scalable production. Another review synthesizes evidence from 2000 to 2025 on antibiotic use, resistance pathways, and environmental risks, particularly those affecting mangrove habitats.

A System-Wide Challenge

Antimicrobial resistance in shrimp production is shaped by interactions among farming practices, antibiotic use, environmental conditions, and public-health protection. Addressing it likely requires coordinated surveillance, more responsible treatment decisions, and attention to pathways beyond individual ponds. Because these systems are interconnected, isolated interventions may have limited effect unless they are supported by broader management and oversight.

From Farm Decisions to Public Risk

Reviews of the global shrimp industry assess the evidence for AMR emergence and dissemination while examining the factors that drive antimicrobial use in aquaculture. They also discuss possible risk-mitigation strategies as the industry seeks a more sustainable future in production. The human impact therefore involves not only farm-level disease management and economic pressures, but also the need to limit potential AMR risks associated with the wider shrimp-production system.

What the resistance screen can tell us

The results distinguish a gene associated with shrimp disease from a resistance gene detected in pond water: the first was confined to shrimp isolates, while qnrVC appeared in one water isolate with an MDR profile. These are different findings, and neither establishes how often such patterns occur beyond the sampled farms.[1]

The study combined susceptibility testing with screening for resistance genes and virulence profiles. Its findings describe the sampled bacteria; they do not by themselves establish transmission to people or quantify health risk.[1]

Where the shrimp findings are bounded

  • The gene’s absence from sampled water does not establish that it is absent from pond water elsewhere or at other times.[1]
Study at a glance
PopulationVibrio parahaemolyticus isolates from Pacific white shrimp and shrimp-farm pond water[1]
SettingSeven provinces in Thailand[1]
Main outcomeAntimicrobial resistance, PMQR genes, pirAB-like virulent gene, and gyrA subtypes[1]
Times cited16[1]

How later studies have used this finding

Later authors cite the study in support of AMR monitoring and alternatives to antibiotic dependence, and in discussion of environmental effects of antimicrobial drugs. These are broader arguments, not outcomes measured in the shrimp-isolate survey.[2] [3]

What the sample leaves unresolved

  • How often does qnrVC occur in pond-water isolates beyond the single MDR isolate reported here?[1]

Terms used in the study

PMQR
Plasmid-mediated quinolone resistance[1]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1016/j.anres.2018.10.010, Alternate LINK

Title: Antimicrobial Resistance And Pirab-Like Profiles Of Vibrio Parahaemolyticus In Pacific White Shrimp

Subject: General Agricultural and Biological Sciences

Journal: Agriculture and Natural Resources

Publisher: Kasetsart University and Development Institute

Authors: Chea Rortana, Worawidh Wajjwalku, Visanu Boonyawiwat, Charuwan Hrianpreecha, Sukanya Thongratsakul, Patamabhorn Amavisit

Published: 2018-08-01

Everything You Need To Know

1

What does antimicrobial resistance in shrimp farming really mean for the shrimp on my plate?

Antimicrobial resistance in shrimp farming means that bacteria like Vibrio parahaemolyticus, which causes acute hepatopancreatic necrosis disease (AHPND), become less susceptible to drugs designed to kill them. While the study showed generally low resistance, the presence of multidrug-resistant (MDR) isolates and the potential for bacteria to acquire plasmid resistance genes means that diseases like AHPND could become harder to treat, posing risks to shrimp farming and potentially affecting the safety of shrimp intended for consumption.

2

Can you explain what acute hepatopancreatic necrosis disease (AHPND) is and why it's a problem for shrimp?

Acute hepatopancreatic necrosis disease (AHPND), previously known as early mortality syndrome (EMS), is a disease affecting shrimp, primarily caused by Vibrio parahaemolyticus carrying Photorhabdus insect-related (Pir) toxins. This disease leads to significant economic losses in shrimp farming due to high mortality rates. The presence of the pirAB-like gene in V. parahaemolyticus isolates indicates the potential for causing AHPND in shrimp populations, as highlighted by its prevalence in shrimp samples within the study.

3

Why is quinolone resistance in Vibrio parahaemolyticus such a big deal, and what does the qnrVC gene have to do with it?

Quinolone resistance in Vibrio parahaemolyticus is concerning because quinolones are important antimicrobials used in both humans and animals. Although the study found that the isolates were not fully resistant to quinolones like ciprofloxacin and enrofloxacin, the presence of the qnrVC quinolone-resistant gene in some isolates suggests a potential for resistance to increase over time. The detection of plasmid-mediated quinolone resistance (PMQR) genes indicates a mechanism by which resistance can spread among bacteria, further complicating treatment options.

4

What does it mean when Vibrio parahaemolyticus isolates are labeled as multidrug-resistant (MDR)?

The presence of multidrug-resistant (MDR) isolates of Vibrio parahaemolyticus indicates that these bacteria are resistant to multiple antimicrobials. In the study, some isolates showed resistance to ampicillin, doxycycline, oxytetracycline and other antimicrobials. The ability of these MDR isolates to acquire plasmid resistance genes means that antimicrobial resistance (AMR) can spread within bacterial populations, making infections more difficult to treat and posing a significant threat to both aquaculture and public health.

5

The study mentions that even low antimicrobial resistance rates are concerning. Why is this the case, and what steps can be taken to reduce the risk?

The study suggests that even low rates of antimicrobial resistance can pose a risk due to the potential for resistance to spread. The detection of plasmid-mediated quinolone resistance (PMQR) genes and multidrug-resistant (MDR) isolates highlights this risk. By implementing responsible antimicrobial practices, maintaining rigorous monitoring programs, and understanding the mechanisms of resistance, the aquaculture industry and public health officials can work to mitigate the risks of AMR and ensure a safer food supply.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.